IBDEI0CM ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17060,0)
 ;;=V11.3^^107^1082^42
 ;;^UTILITY(U,$J,358.3,17060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17060,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,17060,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,17060,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,17061,0)
 ;;=V15.07^^107^1082^43
 ;;^UTILITY(U,$J,358.3,17061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17061,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,17061,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,17061,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,17062,0)
 ;;=V13.4^^107^1082^44
 ;;^UTILITY(U,$J,358.3,17062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17062,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,17062,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,17062,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,17063,0)
 ;;=V12.72^^107^1082^45
 ;;^UTILITY(U,$J,358.3,17063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17063,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,17063,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,17063,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,17064,0)
 ;;=V12.59^^107^1082^46
 ;;^UTILITY(U,$J,358.3,17064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17064,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,17064,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,17064,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,17065,0)
 ;;=V45.81^^107^1082^47
 ;;^UTILITY(U,$J,358.3,17065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17065,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,17065,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,17065,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,17066,0)
 ;;=V15.84^^107^1082^48
 ;;^UTILITY(U,$J,358.3,17066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17066,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,17066,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,17066,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,17067,0)
 ;;=V15.85^^107^1082^53
 ;;^UTILITY(U,$J,358.3,17067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17067,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,17067,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,17067,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,17068,0)
 ;;=V10.72^^107^1082^51
 ;;^UTILITY(U,$J,358.3,17068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17068,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,17068,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,17068,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,17069,0)
 ;;=V15.3^^107^1082^52
 ;;^UTILITY(U,$J,358.3,17069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17069,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,17069,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,17069,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,17070,0)
 ;;=V10.61^^107^1082^26
 ;;^UTILITY(U,$J,358.3,17070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17070,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,17070,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,17070,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,17071,0)
 ;;=V12.03^^107^1082^27
 ;;^UTILITY(U,$J,358.3,17071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17071,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,17071,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,17071,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,17072,0)
 ;;=V10.82^^107^1082^28
 ;;^UTILITY(U,$J,358.3,17072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17072,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,17072,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,17072,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,17073,0)
 ;;=V10.62^^107^1082^30
 ;;^UTILITY(U,$J,358.3,17073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17073,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,17073,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,17073,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,17074,0)
 ;;=V10.63^^107^1082^29
 ;;^UTILITY(U,$J,358.3,17074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17074,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,17074,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,17074,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,17075,0)
 ;;=V11.2^^107^1082^24
 ;;^UTILITY(U,$J,358.3,17075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17075,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,17075,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,17075,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,17076,0)
 ;;=V15.81^^107^1082^40
 ;;^UTILITY(U,$J,358.3,17076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17076,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,17076,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,17076,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,17077,0)
 ;;=V10.43^^107^1082^31
 ;;^UTILITY(U,$J,358.3,17077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17077,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,17077,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,17077,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,17078,0)
 ;;=V12.71^^107^1082^32
 ;;^UTILITY(U,$J,358.3,17078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17078,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,17078,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,17078,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,17079,0)
 ;;=V10.46^^107^1082^33
 ;;^UTILITY(U,$J,358.3,17079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17079,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,17079,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,17079,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,17080,0)
 ;;=V11.0^^107^1082^34
 ;;^UTILITY(U,$J,358.3,17080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17080,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,17080,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,17080,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,17081,0)
 ;;=V10.83^^107^1082^35
 ;;^UTILITY(U,$J,358.3,17081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17081,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,17081,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,17081,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,17082,0)
 ;;=V15.1^^107^1082^36
 ;;^UTILITY(U,$J,358.3,17082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17082,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,17082,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,17082,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,17083,0)
 ;;=V15.82^^107^1082^38
 ;;^UTILITY(U,$J,358.3,17083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17083,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,17083,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
 ;;^UTILITY(U,$J,358.3,17083,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,17084,0)
 ;;=V12.01^^107^1082^37
 ;;^UTILITY(U,$J,358.3,17084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17084,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,17084,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,17084,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,17085,0)
 ;;=V13.01^^107^1082^25
 ;;^UTILITY(U,$J,358.3,17085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17085,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,17085,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,17085,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,17086,0)
 ;;=V12.51^^107^1082^39
 ;;^UTILITY(U,$J,358.3,17086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17086,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,17086,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,17086,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,17087,0)
 ;;=V17.89^^107^1082^1
 ;;^UTILITY(U,$J,358.3,17087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17087,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,17087,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,17087,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,17088,0)
 ;;=V12.54^^107^1082^55
 ;;^UTILITY(U,$J,358.3,17088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17088,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,17088,1,5,0)
 ;;=5^Personal h/o TIA
 ;;^UTILITY(U,$J,358.3,17088,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,17089,0)
 ;;=V12.54^^107^1082^54
 ;;^UTILITY(U,$J,358.3,17089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17089,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,17089,1,5,0)
 ;;=5^Personal h/o Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,17089,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,17090,0)
 ;;=V15.88^^107^1082^50
 ;;^UTILITY(U,$J,358.3,17090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17090,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,17090,1,5,0)
 ;;=5^Personal h/o Fall(s)
 ;;^UTILITY(U,$J,358.3,17090,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,17091,0)
 ;;=V13.59^^107^1082^23
 ;;^UTILITY(U,$J,358.3,17091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17091,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,17091,1,5,0)
 ;;=5^Hx Musculoskletl Dis
 ;;^UTILITY(U,$J,358.3,17091,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,17092,0)
 ;;=V15.52^^107^1082^56
 ;;^UTILITY(U,$J,358.3,17092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17092,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,17092,1,5,0)
 ;;=5^Personal h/o Traum Brain Inj
 ;;^UTILITY(U,$J,358.3,17092,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,17093,0)
 ;;=V70.0^^107^1083^1
 ;;^UTILITY(U,$J,358.3,17093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17093,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,17093,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,17093,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,17094,0)
 ;;=V77.91^^107^1083^2
 ;;^UTILITY(U,$J,358.3,17094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17094,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,17094,1,5,0)
 ;;=5^Screen for High Cholesterol
 ;;^UTILITY(U,$J,358.3,17094,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,17095,0)
 ;;=V76.44^^107^1083^3
 ;;^UTILITY(U,$J,358.3,17095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17095,1,4,0)
 ;;=4^V76.44
